184 related articles for article (PubMed ID: 1826594)
21. Teicoplanin, vancomycin, rifampicin: in-vivo and in-vitro studies with Staphylococcus aureus.
Carper HT; Sullivan GW; Mandell GL
J Antimicrob Chemother; 1987 May; 19(5):659-62. PubMed ID: 2956229
[TBL] [Abstract][Full Text] [Related]
22. The pharmacokinetics and extravascular diffusion of teicoplanin in rabbits and comparative efficacy with vancomycin in an experimental endocarditis model.
Contrepois A; Joly V; Abel L; Pangon B; Vallois JM; Carbon C
J Antimicrob Chemother; 1988 May; 21(5):621-31. PubMed ID: 2968969
[TBL] [Abstract][Full Text] [Related]
23. Serum bactericidal titer as a predictor of outcome in endocarditis.
Hackbarth CJ; Chambers HF; Sande MA
Eur J Clin Microbiol; 1986 Feb; 5(1):93-7. PubMed ID: 2938947
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients.
Leport C; Perronne C; Massip P; Canton P; Leclercq P; Bernard E; Lutun P; Garaud JJ; Vilde JL
Antimicrob Agents Chemother; 1989 Jun; 33(6):871-6. PubMed ID: 2527483
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment of right-sided native valve methicillin-resistant Staphylococcus aureus endocarditis and septicaemia with teicoplanin and rifampicin: a case report.
Saravu K; Mukhopadhyay C; Satyanarayanan V; Pai A; Komaranchath AS; Munim F; Shastry BA; Tom D
Scand J Infect Dis; 2012 Jul; 44(7):544-7. PubMed ID: 22385220
[TBL] [Abstract][Full Text] [Related]
26. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
Galetto DW; Boscia JA; Kobasa WD; Kaye D
J Infect Dis; 1986 Jul; 154(1):69-75. PubMed ID: 2940303
[TBL] [Abstract][Full Text] [Related]
27. Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.
Peeters O; Ferry T; Ader F; Boibieux A; Braun E; Bouaziz A; Karsenty J; Forestier E; Laurent F; Lustig S; Chidiac C; Valour F;
BMC Infect Dis; 2016 Nov; 16(1):622. PubMed ID: 27809799
[TBL] [Abstract][Full Text] [Related]
28. Teicoplanin in the treatment of gram-positive-bacterial endocarditis.
Martino P; Venditti M; Micozzi A; Brandimarte C; Gentile G; Santini C; Serra P
Antimicrob Agents Chemother; 1989 Aug; 33(8):1329-34. PubMed ID: 2529815
[TBL] [Abstract][Full Text] [Related]
29. Teicoplanin in the treatment of serious infection.
Schaison G; Graninger W; Bouza E
J Chemother; 2000 Nov; 12 Suppl 5():26-33. PubMed ID: 11131961
[TBL] [Abstract][Full Text] [Related]
30. Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin.
Greenberg RN
Antimicrob Agents Chemother; 1990 Dec; 34(12):2392-7. PubMed ID: 2150908
[TBL] [Abstract][Full Text] [Related]
31. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
Atahan E; Gul M; Ergun Y; Eroglu E
Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
[TBL] [Abstract][Full Text] [Related]
32. Use of a glycopeptide antibiotic, teicoplanin, in the treatment of septicaemia caused by gram-positive bacteria.
Webster A; Wilson AP; Treasure T; Grüneberg RN
Int J Clin Pharmacol Res; 1988; 8(2):95-8. PubMed ID: 2967800
[TBL] [Abstract][Full Text] [Related]
33. Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection.
Peetermans WE; Hoogeterp JJ; Hazekamp-van Dokkum AM; van den Broek P; Mattie H
Antimicrob Agents Chemother; 1990 Oct; 34(10):1869-74. PubMed ID: 2149812
[TBL] [Abstract][Full Text] [Related]
34. Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity.
Kureishi A; Jewesson PJ; Rubinger M; Cole CD; Reece DE; Phillips GL; Smith JA; Chow AW
Antimicrob Agents Chemother; 1991 Nov; 35(11):2246-52. PubMed ID: 1839490
[TBL] [Abstract][Full Text] [Related]
35. Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis.
Kaatz GW; Barriere SL; Schaberg DR; Fekety R
Antimicrob Agents Chemother; 1987 Apr; 31(4):527-30. PubMed ID: 3649202
[TBL] [Abstract][Full Text] [Related]
36. Comparative therapeutic efficacy of teicoplanin and vancomycin in normal and in neutropenic mice infected with Staphylococcus haemolyticus.
Torney HL; Balistreri FJ; Kenny MT; Cheng WD
J Antimicrob Chemother; 1991 Aug; 28(2):261-9. PubMed ID: 1838105
[TBL] [Abstract][Full Text] [Related]
37. Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin.
Brunet F; Vedel G; Dreyfus F; Vaxelaire JF; Giraud T; Schremmer B; Monsallier JF
Eur J Clin Microbiol Infect Dis; 1990 Feb; 9(2):145-7. PubMed ID: 2138543
[TBL] [Abstract][Full Text] [Related]
38. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
Cosgrove SE; Vigliani GA; Fowler VG; Abrutyn E; Corey GR; Levine DP; Rupp ME; Chambers HF; Karchmer AW; Boucher HW
Clin Infect Dis; 2009 Mar; 48(6):713-21. PubMed ID: 19207079
[TBL] [Abstract][Full Text] [Related]
39. [Efficacy of teicoplanin in 25 cases of severe infections caused by gram-positive cocci].
Potel G; Touzé MD; Meignier M; Reynaud A; Baron D
Pathol Biol (Paris); 1988 May; 36(5):531-5. PubMed ID: 2970058
[TBL] [Abstract][Full Text] [Related]
40. Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis.
McGrath BJ; Kang SL; Kaatz GW; Rybak MJ
Antimicrob Agents Chemother; 1994 Sep; 38(9):2034-40. PubMed ID: 7811015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
